Reference : Prognostic significance of aberrant promoter hypermethylation of CpG islands in patie...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/87469
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
English
Amara, Khaled [ > > ]
Trimeche, Mounir [ > > ]
Ziadi, Sonia [ > > ]
Laatiri, Adnen [ > > ]
Hachana, Mohamed Ridha [Université de Liège - ULg > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén. >]
Korbi, Sadok [ > > ]
Oct-2008
Annals of Oncology
Oxford University Press
19
10
1774-1786
Yes (verified by ORBi)
International
0923-7534
1569-8041
London
United Kingdom
[en] diffuse large B-cell lymphomas ; hypermethylation ; prognosis ; tumor suppressor genes
[en] Background: Diffuse large B-cell lymphoma (DLBCL) exhibits heterogeneous clinical features and a marked variable
response to treatment.
Patients and methods: We investigated the prognostic significance of the methylation status of DAPK, GSTP1,
P14, P15, P16, P33, RB1, SHP1, CDH1, APC, BLU, VHL, TIMP3, and RASSF1A genes in 46 DLBCL specimens from
Tunisian patients. Methylation status of each gene was correlated with clinicopathological parameters including the
International Prognostic Index (IPI), the germinal center immunophenotype, and response to treatment and survival.
Overall survival (OS) and disease-free survival (DFS) rates were calculated by the Kaplan–Meier method and
differences were compared with the log-rank test.
Results: Hypermethylation of SHP1 was associated with elevated lactate dehydrogenase level (P = 0.031). P16 and
VHL were frequently hypermethylated in patients with high IPI scores (P = 0.006 and 0.004) and a performance status
of two or more (P = 0.007 and 0.047). In addition, hypermethylation of P16 was significantly associated with advanced
clinical stages and B symptoms (P = 0.041 and 0.012). Interestingly, hypermethylation of DAPK was significantly
correlated with resistance to treatment (P = 0.023). With regard to survival rates, promoter hypermethylation of DAPK,
P16, and VHL were significantly associated with shortened OS (P = 0.003, 0.001, and 0.017, respectively) and DFS
(P = 0.006, 0.003, and 0.046, respectively). In multivariate analysis, hypermethylation of DAPK remains an
independent prognostic factor in predicting shortened OS (P = 0.001) and DFS (P = 0.024), as well as the IPI and the
germinal center status.
Conclusions: This study demonstrates that DLBCLs with hypermethylated P16, VHL, DAPK, and SHP1 commonly
show a biologically aggressive phenotype and worse prognosis. Interestingly, hypermethylation of DAPK was found to
be an independent prognostic factor that may be used in conjunction with the conventional prognostic factors such as
the IPI and the germinal center status.
Departments of Pathology and Clinical Hematology, Farhat-Hached Hospital of Sousse, Tunisia
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/87469

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Prognostic significance of aberrant promoter.pdfAuthor preprint347.97 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.